Based on DA8600 sequencing platform, we operate 4 reference laboratories domestically, built associated laboratories with over 30 provinces' reproductive centers and conducted business with over 200 domestic medical institutions. In addition, the platform has a wide range of application fields, including: maternity and child health care, genetic disease, tumor personalized treatment, drug metabolism, blood system diseases and infectious diseases.
B
A
S
E
C
A
R
E
Instrument/Diagnosis
High-throughput sequencer
AS one of the first sequencing system approved by CFDA (Approval No.20143221961), DA8600 is specially designed for clinical application and is applicable to various genetic research and services.
Product introduction
High-throughput Sequencing System
There are two requirements for equipment used in clinical gene detection, first, it need to be approved by CFDA, second, it should have medium-throughput so that it can meet clinical application requirement properly. With introduced technology from Thermofisher, DA8600 is a High-throughput sequencing system developed by Daan gene, as the one of the first sequencing system approved by CFDA, it can be widely used by various medical institutions to provide comprehensive genetic testing services.
Advantages
Fast
Time-saving, with genetic testing done in only 3 hours
Medium-throughput
Reasonable detection cost based on short report cycle
Good compatibility
Simultaneous sequencing for samples of different detections
Good stability
Experienced, more than one million clinical samples were verified
Easy to operate
Maximized flexibility based on the well-designed system
Wide application
Applicable for noninvasive prenatal,tumor and fertility field
Service process
